Thermo Fisher Scientific Inc. (NYSE:TMO) is Montag & Caldwell LLC’s 3rd Largest Position

Montag & Caldwell LLC reduced its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 322,892 shares of the medical research company’s stock after selling 11,057 shares during the period. Thermo Fisher Scientific comprises 4.9% of Montag & Caldwell LLC’s portfolio, making the stock its 3rd largest holding. Montag & Caldwell LLC owned 0.08% of Thermo Fisher Scientific worth $94,827,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. FMR LLC increased its stake in shares of Thermo Fisher Scientific by 33.5% in the first quarter. FMR LLC now owns 11,572,581 shares of the medical research company’s stock worth $3,167,647,000 after purchasing an additional 2,900,868 shares in the last quarter. BlackRock Inc. increased its stake in shares of Thermo Fisher Scientific by 4.1% in the first quarter. BlackRock Inc. now owns 27,251,678 shares of the medical research company’s stock worth $7,459,327,000 after purchasing an additional 1,074,400 shares in the last quarter. Marshall Wace LLP increased its stake in shares of Thermo Fisher Scientific by 361.8% in the first quarter. Marshall Wace LLP now owns 775,103 shares of the medical research company’s stock worth $212,161,000 after purchasing an additional 607,245 shares in the last quarter. Janus Henderson Group PLC increased its stake in shares of Thermo Fisher Scientific by 22.9% in the second quarter. Janus Henderson Group PLC now owns 2,986,916 shares of the medical research company’s stock worth $877,186,000 after purchasing an additional 555,802 shares in the last quarter. Finally, Swedbank purchased a new stake in shares of Thermo Fisher Scientific in the first quarter worth $111,710,000. 88.21% of the stock is owned by institutional investors and hedge funds.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the completion of the transaction, the chief financial officer now owns 40,029 shares in the company, valued at $10,739,380.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the transaction, the chief executive officer now owns 342,193 shares of the company’s stock, valued at approximately $97,466,832.19. The disclosure for this sale can be found here. Insiders have sold 52,775 shares of company stock valued at $14,986,676 over the last ninety days. 0.45% of the stock is currently owned by corporate insiders.



TMO traded up $3.86 during trading on Thursday, hitting $273.34. 51,785 shares of the company traded hands, compared to its average volume of 1,592,969. The company has a market cap of $108.93 billion, a P/E ratio of 24.54, a PEG ratio of 1.78 and a beta of 1.11. The stock has a 50-day moving average price of $287.70. Thermo Fisher Scientific Inc. has a 1 year low of $208.34 and a 1 year high of $305.45. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.07 and a current ratio of 1.49.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.01 by $0.03. The company had revenue of $6.32 billion during the quarter, compared to analysts’ expectations of $6.31 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. Thermo Fisher Scientific’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the company posted $2.75 earnings per share. Analysts anticipate that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be paid a dividend of $0.19 per share. The ex-dividend date is Monday, September 16th. This represents a $0.76 annualized dividend and a yield of 0.28%. Thermo Fisher Scientific’s payout ratio is 6.83%.

A number of analysts have recently issued reports on the stock. Argus increased their price objective on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price objective for the company in a research note on Wednesday, June 12th. Needham & Company LLC increased their price objective on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Credit Suisse Group reissued a “buy” rating and issued a $310.00 price objective on shares of Thermo Fisher Scientific in a research note on Wednesday, July 31st. Finally, BTIG Research increased their price objective on shares of Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $303.17.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Swap

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.